Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis.

Jian J, Pang Y, Yan HH, Min Y, Achyut BR, Hollander MC, Lin PC, Liang X, Yang L.

Oncotarget. 2017 Apr 25;8(17):27725-27739. doi: 10.18632/oncotarget.9486.

2.

Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.

Shi H, Zhang J, Han X, Li H, Xie M, Sun Y, Liu W, Ba X, Zeng X.

Int J Cancer. 2017 Mar 15;140(6):1370-1383. doi: 10.1002/ijc.30538.

3.

Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition.

Gao D, Joshi N, Choi H, Ryu S, Hahn M, Catena R, Sadik H, Argani P, Wagner P, Vahdat LT, Port JL, Stiles B, Sukumar S, Altorki NK, Rafii S, Mittal V.

Cancer Res. 2012 Mar 15;72(6):1384-94. doi: 10.1158/0008-5472.CAN-11-2905. Epub 2012 Jan 26.

4.

CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ.

Yan HH, Jiang J, Pang Y, Achyut BR, Lizardo M, Liang X, Hunter K, Khanna C, Hollander C, Yang L.

Cancer Res. 2015 Dec 15;75(24):5283-98. doi: 10.1158/0008-5472.CAN-15-2282-T. Epub 2015 Oct 19.

5.

Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche.

Sceneay J, Chow MT, Chen A, Halse HM, Wong CS, Andrews DM, Sloan EK, Parker BS, Bowtell DD, Smyth MJ, Möller A.

Cancer Res. 2012 Aug 15;72(16):3906-11. doi: 10.1158/0008-5472.CAN-11-3873. Epub 2012 Jul 2.

6.

Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung.

Yan HH, Pickup M, Pang Y, Gorska AE, Li Z, Chytil A, Geng Y, Gray JW, Moses HL, Yang L.

Cancer Res. 2010 Aug 1;70(15):6139-49. doi: 10.1158/0008-5472.CAN-10-0706. Epub 2010 Jul 14.

7.

Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.

Wang Z, Xiong S, Mao Y, Chen M, Ma X, Zhou X, Ma Z, Liu F, Huang Z, Luo Q, Ouyang G.

J Pathol. 2016 Aug;239(4):484-95. doi: 10.1002/path.4747. Epub 2016 Jul 8.

PMID:
27193093
8.

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ.

Cancer Cell. 2009 Jan 6;15(1):35-44. doi: 10.1016/j.ccr.2008.11.012.

9.

Premetastatic soil and prevention of breast cancer brain metastasis.

Liu Y, Kosaka A, Ikeura M, Kohanbash G, Fellows-Mayle W, Snyder LA, Okada H.

Neuro Oncol. 2013 Jul;15(7):891-903. doi: 10.1093/neuonc/not031. Epub 2013 Apr 17.

10.

Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.

Souza LE, Almeida DC, Yaochite JN, Covas DT, Fontes AM.

Exp Cell Res. 2016 Jul 15;345(2):141-9. doi: 10.1016/j.yexcr.2015.05.021. Epub 2015 May 28.

PMID:
26027946
11.

Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs.

Sharma SK, Chintala NK, Vadrevu SK, Patel J, Karbowniczek M, Markiewski MM.

J Immunol. 2015 Jun 1;194(11):5529-38. doi: 10.4049/jimmunol.1403215. Epub 2015 Apr 24.

12.

Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.

Das SK, Guo C, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Emdad L, Subler MA, Windle JJ, Sarkar D, Wang XY, Fisher PB.

Oncotarget. 2016 Jul 26;7(30):46848-46861. doi: 10.18632/oncotarget.10040.

13.

Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.

Spallanzani RG, Dalotto-Moreno T, Raffo Iraolagoitia XL, Ziblat A, Domaica CI, Avila DE, Rossi LE, Fuertes MB, Battistone MA, Rabinovich GA, Salatino M, Zwirner NW.

Cancer Immunol Immunother. 2013 Dec;62(12):1781-95. doi: 10.1007/s00262-013-1483-x. Epub 2013 Oct 11.

PMID:
24114144
14.

PF4 Promotes Platelet Production and Lung Cancer Growth.

Pucci F, Rickelt S, Newton AP, Garris C, Nunes E, Evavold C, Pfirschke C, Engblom C, Mino-Kenudson M, Hynes RO, Weissleder R, Pittet MJ.

Cell Rep. 2016 Nov 8;17(7):1764-1772. doi: 10.1016/j.celrep.2016.10.031.

15.

TGFβ modulates inflammatory cytokines and growth factors to create premetastatic microenvironment and stimulate lung metastasis.

Ye Y, Liu S, Wu C, Sun Z.

J Mol Histol. 2015 Oct;46(4-5):365-75. doi: 10.1007/s10735-015-9633-4. Epub 2015 Jul 25.

PMID:
26208571
16.

Gr-1+CD11b+ cells are responsible for tumor promoting effect of TGF-β in breast cancer progression.

Li Z, Pang Y, Gara SK, Achyut BR, Heger C, Goldsmith PK, Lonning S, Yang L.

Int J Cancer. 2012 Dec 1;131(11):2584-95. doi: 10.1002/ijc.27572. Epub 2012 May 8.

17.

High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4.

Daly TJ, LaRosa GJ, Dolich S, Maione TE, Cooper S, Broxmeyer HE.

J Biol Chem. 1995 Oct 6;270(40):23282-92.

18.

Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.

Zhou J, Donatelli SS, Gilvary DL, Tejera MM, Eksioglu EA, Chen X, Coppola D, Wei S, Djeu JY.

Sci Rep. 2016 Jul 13;6:29521. doi: 10.1038/srep29521.

19.

The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.

Wang J, Su X, Yang L, Qiao F, Fang Y, Yu L, Yang Q, Wang Y, Yin Y, Chen R, Hong Z.

Int J Cancer. 2016 Jun 1;138(11):2688-99. doi: 10.1002/ijc.29998. Epub 2016 Jan 25.

20.

Platelet factor-4 and its p17-70 peptide inhibit myeloma proliferation and angiogenesis in vivo.

Yang L, Du J, Hou J, Jiang H, Zou J.

BMC Cancer. 2011 Jun 21;11:261. doi: 10.1186/1471-2407-11-261.

Supplemental Content

Support Center